All News

The CDC reported progress with the current status of the 3 strategies within the national initiative, Ending the HIV Epidemic: A Plan for America.

The immunogenicity and safety of hepatitis B surface antigen (HBsAg)/CpG 1018 was assessed in patients with diabetes aged 60 to 70 years.

A retrospective cohort study was the second largest evaluation to date of sodium polystyrene sulphonate use and safety in patients with chronic kidney disease.

What is causing a patient’s memory loss?

Icosapent ethyl is the first FDA-approved prescription form of fish oil to reduce cardiovascular risk among patients with triglyceride levels as an add-on to maximally tolerated statin therapy.

The supplemental new drug application approval expands the patient population who stand to benefit from riluzole to include patients with ALS for whom swallowing is difficult and requires the use of percutaneous endoscopic gastrostomy feeding tube.

Top news of the day from across the health care landscape.

Results of the DAPA-HF trial demonstrate the efficacy and safety of dapagliflozin in patients with heart failure.

In this study, researchers wanted to evaluate the frequency of reduced immunoglobulin concentrations and its association with immunotherapy and disease course in 2 independent cohorts with multiple sclerosis.

The Trend Report is a synthesis of multiple research projects exploring risk factors that influence medication adherence, along with background and implications.

A report suggests that addressing financial barriers to antiretroviral therapy adherence may improve levels of viral suppression.

More men than women initiate kidney replacement therapy despite a higher prevalence of chronic kidney disease seen in women.

The FDA has granted accelerated approval to golodirsen injection (Vyondys 53, Sarepta Therapeutics) to treat patients with Duchenne muscular dystrophy (DMD) who have confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

The etonogestrel/ethinyl estradiol vaginal ring is a flexible birth control used to prevent pregnancy.

Tofacitinib is indicated for the treatment of adult patients with severely active ulcerative colitis, severely active rheumatoid arthritis (RA), or psoriatic arthritis (PsA).

Transform Oncology Care uses results of broad-panel gene sequencing tests to help oncologists identify appropriate treatment regimens based on their patients clinical and genetic profiles.

Carefully implemented order sets may encourage evidence-based or institution-specific care though the influence of provider behavior.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The technology known as sci-Plex can analyze millions of cells to reveal how these cells may react when treated with a drug.

Top news of the day from across the health care landscape.

The FDA has granted Fast Track Designation for the development of PH94B (VistaGen Therapeutics), a neuroactive nasal spray for on-demand treatment of social anxiety disorder (SAD).

The FDA has approved the Unidose Liquid System (AptarGroup Inc) as the first and only nasal rescue treatment for acute repetitive seizures in patients with epilepsy.

The US Department of Health and Human Services (HHS) has entered an agreement with Sanofi Pasteur to increase the company's domestic pandemic influenza vaccine production capabilities.

Top news of the day from across the health care landscape.

Jesse C. Dresser, Esq explains how DIR fees affect specialty pharmacists at the NASP Annual Meeting in Washington, DC.